The “Open co-design workshop on next generation tools to manage ALS and MS” took plane on June 3rd and follows a series of two previous events opened only to the project’s consortium members aimed at exploring and defining the BRAINTEASER stakeholders’ ecosystem, the user’s needs and profiles and the potential clinical use of the project’s technology. During the open co-design workshop, the initial BRAINTEASER technical solution was presented. The external experts and the audience was involved in a collaborative and participative discussion on clinical unmet needs, disease course, clinical practice and new emerging research on ALS and MS to assess the BRAINTEASER solution and propose possible refinements.
